Do estrogen antagonists and anti-androgens prevent the COVID-19’s pulmonary involvement?

Authors

  • Mehrdad Jalalian Editor-in-Chief, Electronic Physician Journal, Mashhad, Iran.

Keywords:

COVID-19, Prophylaxis, Coronavirus, ACE2, S-protein, Estrogen, Testosterone

Abstract

Male and female hormones are upregolators of expression of Angiotensin-converting Enzyme 2 (ACE2) gene. This short article proposes a hypothesis about the potential effect of estrogen antagonists and anti-androgens in preventing pulmonary involvement in COVID-19 infection through their downregulatory effect on ACE2 expression.

References

Wu Z1, McGoogan JM1.Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020 Feb 24. DOI: 10.1001/jama.2020.2648. PMID: 32091533. [Epub ahead of print]

Cai J, Xu J, Lin D, Yang Z, Xu L, Qu Z, Zhang Y et al. A Case Series of children with 2019 novel coronavirus infection: clinical and epidemiological features. A Case Series of children with 2019 novel coronavirus infection: clinical and epidemiological features. Clin Infect Dis. 2020 Feb 28. DOI: 10.1093/cid/ciaa198. PMID: 32112072

Hussin A.RothanaSiddappa N.Byrareddy. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. Journal of Autoimmunity. Available online 26 February 2020. DOI: 10.1016/j.jaut.2020.102433, In Press

Downloads

Published

2021-12-11

Issue

Vol. 12 No. 1 (2020): January - Mars 2020

Section

Articles

License

Copyright (c) 2020 Knowledge Kingdom Publishing

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.